PCA3 – Our position

Summary

The PCA3 test is a new test available in the UK for the first time to specialists looking after men who may have prostate cancer.

The test could improve the diagnosis of prostate cancer by reducing the number of unnecessary biopsies of the prostate. Some men experience repeated biopsies when they are having a prostate problem investigated. This is because the levels of PSA (Prostate Specific Antigen) in a man’s blood remain elevated but no clear results emerge from a biopsy. There is a lingering suspicion that cancer could be present and the biopsy is repeated, often more than once.

The PCA3 test can show how likely it is that prostate cancer is present - and if it is unlikely, unnecessary biopsies can be avoided.

The Prostate Cancer Charity considers the test to be a useful development in prostate cancer diagnosis because of its potential to cut down on unnecessary pain and side effects from invasive biopsies.

It is a hospital based test for men who are already being investigated for a prostate problem that might turn out to be prostate cancer. It is not a test that can be done on request by a GP for a man who fears he may have prostate cancer. Its potential, or otherwise, as a screening test, is unknown.

The NHS and specialists who diagnose prostate cancer now have the opportunity to begin to use the new test and become familiar with it. As with anything new, demand has to grow and provision of it will vary across the country as it is not part of standard practice. In time it may become standard practice as evidence in its favour begins to accumulate.

It is not yet clear at this time whether Trusts or Health Boards will pay for men to have it in their areas, or not.

We welcome your feedback

The Prostate Cancer Charity is interested in hearing from any health professional in the NHS who would like to use the test but who has been prevented from doing so for any non-clinical reason.

We are also interested to hear from any man for whom the test is appropriate but whose specialist has been refused permission to use it on the grounds of cost or other reasons. Contact Lilas Allen Head of Media and Public Affairs.

PCA3 Background >>>